Landscapes / Companies
Sinotau Pharmaceutical Group not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
2 in Phase 2
Drugs
5
in active trials · 6 in all
Trials
5 active
11 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 1 Jun 2027Phase 2/3 trial completes | |||
| Next date | 1 Jun 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Advanced Neuroendocrine Neoplasm | ||||
| Open drug page | |||||
— |
Phase 3 | Jun 2027Phase 3 trial completes | |||
| Next date | Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Coronary Artery Disease(CAD) | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Alzheimer Disease, Neurofibrillary Tangle | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Dec 2026Phase 2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Ischemic Cardiomyopathy, Heart Failure | ||||
| Open drug page | |||||
Lu-XT033not checked |
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | ||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Prostate Cancer | ||||
| Open drug page | |||||
About
- No active trial
- Flotufolastat F-18
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021